Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. (Q27824811)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. |
scientific article |
Statements
2 references
Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor (English)
Neal J Meropol
Patrick J Loehrer
Michael N Needle
Justin Kopit
Identifiers
2 references
2 references